The 2-Minute Rule for Healthcare News
Novo CEO pressed by Senate to cut charges of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would take into account new talks with insurers in regards to the listing charges of Wegovy and copyright when they pledge to keep the medicines on their formularies.Insurers will keep on vertically